Literature DB >> 22337246

Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.

Sara S McCoy1, Cynthia S Crowson, Sherine E Gabriel, Eric L Matteson.   

Abstract

OBJECTIVE: To determine the frequency of hypothyroidism in patients with rheumatoid arthritis (RA), and to elucidate the association of hypothyroidism and development of cardiovascular disease (CVD) in these patients.
METHODS: A retrospective medical record review was performed using all incident cases of adult-onset RA from Olmsted County, MN, USA, that fulfilled criteria for RA in the years 1988-2007. Patients with and without thyroid disease were followed longitudinally for the development of CVD.
RESULTS: A cohort of 650 patients with RA and an age and sex-matched comparison cohort of 650 patients without RA was assembled (both cohorts mean age 55.8 yrs; 69% were women). There was no significant difference between cohorts in the presence of hypothyroid disease or subclinical hypothyroidism at time of RA diagnosis. No significant difference was found in the cumulative incidence of hypothyroid disease between the 2 cohorts. Hypothyroid disease was found to be significantly associated with CVD in patients with RA (hazard ratio 2.0; 95% CI 1.1, 3.6). This difference remained significant and unchanged after adjustment for traditional CV risk factors (HR 2.0; 95% CI 1.1, 3.6).
CONCLUSION: No significant difference was found in either incidence or prevalence of hypothyroidism between patients with and those without RA. Hypothyroid disease was significantly associated with CVD in patients with RA, even after adjustment for other traditional CV risk factors.

Entities:  

Mesh:

Year:  2012        PMID: 22337246      PMCID: PMC3518421          DOI: 10.3899/jrheum.111076

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  46 in total

1.  Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A T Chan; Z Al-Saffar; R C Bucknall
Journal:  Rheumatology (Oxford)       Date:  2001-03       Impact factor: 7.580

Review 2.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

3.  Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.

Authors:  A E Hak; H A Pols; T J Visser; H A Drexhage; A Hofman; J C Witteman
Journal:  Ann Intern Med       Date:  2000-02-15       Impact factor: 25.391

4.  Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?

Authors:  Z Efstathiadou; S Bitsis; H J Milionis; A Kukuvitis; E T Bairaktari; M S Elisaf; A Tsatsoulis
Journal:  Eur J Endocrinol       Date:  2001-12       Impact factor: 6.664

5.  Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure.

Authors:  W M Tunbridge; D C Evered; R Hall; D Appleton; M Brewis; F Clark; J G Evans; E Young; T Bird; P A Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1977-12       Impact factor: 3.478

6.  Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

Authors:  Hyon K Choi; Miguel A Hernán; John D Seeger; James M Robins; Frederick Wolfe
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

7.  Plasma triglyceride metabolism in thyroid disease.

Authors:  E A Nikkilä; M Kekki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

8.  Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial.

Authors:  Mirjam Christ-Crain; Christian Meier; Merih Guglielmetti; Peter R Huber; Walter Riesen; Jean Jacques Staub; Beat Müller
Journal:  Atherosclerosis       Date:  2003-02       Impact factor: 5.162

9.  Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.

Authors:  Stefano Taddei; Nadia Caraccio; Agostino Virdis; Angela Dardano; Daniele Versari; Lorenzo Ghiadoni; Antonio Salvetti; Ele Ferrannini; Fabio Monzani
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

10.  Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy.

Authors:  Frederick Wolfe; Kaleb Michaud
Journal:  Am J Med       Date:  2004-03-01       Impact factor: 4.965

View more
  11 in total

Review 1.  Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics.

Authors:  Ivica Lazúrová; Ivana Jochmanová; Karim Benhatchi; Stefan Sotak
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  The prevalence of thyroid dysfunction and autoimmune thyroid disease in patients with rheumatoid arthritis.

Authors:  Mahsa Bagherzadeh-Fard; Mohammad Amin Yazdanifar; Mohammad Aghaali; Maryam Masoumi
Journal:  BMC Rheumatol       Date:  2022-10-24

Review 3.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 4.  [Gender-specific differences in comorbidities of rheumatoid arthritis].

Authors:  K Albrecht
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

5.  [Multimorbidity in elderly rheumatic patients part 1].

Authors:  H-J Lakomek; T Brabant; M Lakomek; D Lüttje
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

6.  Autoimmune thyroid disease in rheumatoid arthritis: a global perspective.

Authors:  Jorge Cárdenas Roldán; Jenny Amaya-Amaya; Juan Castellanos-de la Hoz; Juliana Giraldo-Villamil; Gladys Montoya-Ortiz; Paola Cruz-Tapias; Adriana Rojas-Villarraga; Rubén D Mantilla; Juan-Manuel Anaya
Journal:  Arthritis       Date:  2012-11-18

7.  Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.

Authors:  Yu-Lan Chen; Jian-Zi Lin; Ying-Qian Mo; Jin-Jian Liang; Qian-Hua Li; Cheng-Jing Zhou; Xiu-Ning Wei; Jian-Da Ma; Ze-Hong Yang; Dong-Hui Zheng; Lie Dai
Journal:  PeerJ       Date:  2018-01-04       Impact factor: 2.984

Review 8.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

9.  Co-morbidity in patients with early rheumatoid arthritis - inflammation matters.

Authors:  Lena Innala; Clara Sjöberg; Bozena Möller; Lotta Ljung; Torgny Smedby; Anna Södergren; Staffan Magnusson; Solbritt Rantapää-Dahlqvist; Solveig Wållberg-Jonsson
Journal:  Arthritis Res Ther       Date:  2016-01-28       Impact factor: 5.156

10.  Coexistence of endocrinopathies in children with rheumatic diseases.

Authors:  Doha Alhomaidah; Afaf Alsagheir; Sulaiman M Al-Mayouf
Journal:  Int J Pediatr Adolesc Med       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.